Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Safety Trial of CTX0E03 Drug Product Delivered Intracranially in the Treatment of Patients With Stable Ischemic Stroke

NCT01151124 is registered in ClinicalTrials.gov with ReNeuron Limited as lead sponsor.

NCT NCT01151124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01151124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Safety Trial of CTX0E03 Drug Product Delivered Intracranially in the Treatment of Patients With Stable Ischemic Stroke
Lead sponsor
ReNeuron Limited
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2010
Completion date
October 31, 2022
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke